Healthcare Policy Pop podcast

Suspicious CVS Announcement 🤄

0:00
4:23
Rewind 15 seconds
Fast Forward 15 seconds

Alan Gilbert, Vice President for Policy at Purchaser Business Group on Health, discusses whether CVS’s new pharmacy reimbursement model will provide transparency and decrease drug prices; and HHS has created regulations requiring more transparency on AI used in clinical settings.

STAT News Article: CVS’s new drug payment plan won’t lower patients’ prices, experts warn

CNN News Article: CVS will change the way it prices prescription drugs

Politico News Article: HHS takes first stab at AI regs

Ā 

More episodes from "Healthcare Policy Pop"